Hospira (HSP) Receives FDA Warning Letter for Irungattukottai Facility
Tweet Send to a Friend
On May 29, 2013, Hospira, Inc. (NYSE: HSP) received a warning letter from the U.S. Food and Drug Administration (“FDA”) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
